How big is the Sickle Cell Treatment Market?

The Sickle Cell Treatment Market size is expected to reach USD 3.32 billion in 2024 and grow at a CAGR of 12.98% to reach USD 6.11 billion by 2029. Read More

What is the current Sickle Cell Treatment Market size?

In 2024, the Sickle Cell Treatment Market size is expected to reach USD 3.32 billion. Read More

Who are the key players in Sickle Cell Treatment Market?

Novartis AG, Emmaus Medical Inc., Addmedica, Medunik USA Inc. and Global Blood Therapeutics Inc are the major companies operating in the Sickle Cell Treatment Market. Read More

Which is the fastest growing region in Sickle Cell Treatment Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Sickle Cell Treatment Market?

In 2024, the North America accounts for the largest market share in Sickle Cell Treatment Market. Read More

What years does this Sickle Cell Treatment Market cover, and what was the market size in 2023?

In 2023, the Sickle Cell Treatment Market size was estimated at USD 2.94 billion. The report covers the Sickle Cell Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Sickle Cell Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Sickle Cell Treatment Market - Size & Growth Analysis

Sickle Cell Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Sickle Cell Treatment Market Growth Trends and is Segmented by Treatment Modality (Bone Marrow Transplant, Blood Transfusion, and Pharmacotherapy), End User (Hospitals, Specialty Clinics, and Other End Users), Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Size and Forecast are Provided in terms of Value (in USD million) for the above segments.

Sickle Cell Treatment Industry Overview

The sickle cell treatment market is highly competitive, with the presence of several regional and global companies. Companies are taking initiatives to develop novel therapies in the market studied. Some of the players include Novartis AG, Global Blood Therapeutics Inc., Emmaus Medical Inc., Addmedica, Medunik USA Inc., and Bristol-Myers Squibb Company.